U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07810569) titled 'Ocular Surface Changes and Meibomian Gland Dysfunction in Rheumatologic Patients' on Sept. 03.
Brief Summary: This observational study aims to assess the frequency and severity of Meibomian Gland Dysfunction (MGD) and associated ocular surface changes in patients with systemic autoimmune rheumatic diseases compared with healthy volunteers.
Meibomian glands are specialized glands in the eyelids that produce the lipid layer of tears, preventing tear evaporation. Systemic inflammation in rheumatologic conditions may affect these glands, leading to dry eye symptoms and ocular surface damage.
A total of 150 participants (120 rheumatol...